These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11116726)

  • 1. Nightmares with topical beta-blocker.
    Negi A; Thoung D; Dabbous F
    Eye (Lond); 2000 Oct; 14 Pt 5():813-4. PubMed ID: 11116726
    [No Abstract]   [Full Text] [Related]  

  • 2. Peyronie's disease following long-term use of topical timolol.
    Ross JJ; Rahman I; Walters RF
    Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis due to the beta-blocker betaxolol in eyedrops, with cross-sensitivity to timolol.
    Nino M; Napolitano M; Scalvenzi M
    Contact Dermatitis; 2010 May; 62(5):319-20. PubMed ID: 20536484
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic contact dermatitis from carteolol and timolol in eyedrops.
    Quiralte J; Florido F; de San Pedro BS
    Contact Dermatitis; 2000 Apr; 42(4):245. PubMed ID: 10750865
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
    Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
    Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interstitial lung disease induced by timolol eye solution].
    Vandezande LM; Gallouj K; Lamblin C; Fourquet B; Maillot E; Wallaert B
    Rev Mal Respir; 1999 Feb; 16(1):91-3. PubMed ID: 10091266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung-function and glaucoma treatment--a cause for concern?
    Collum LM
    Ir Med J; 1995; 88(1):16. PubMed ID: 7737834
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta-blocking treatment (author's transl)].
    Scharrer A; Ober M
    Klin Monbl Augenheilkd; 1981 Nov; 179(5):362-3. PubMed ID: 6121929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker eye drops.
    Nurs Times; 2006 May 30-Jun 5; 102(22):29. PubMed ID: 16764382
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers.
    Koch P
    Contact Dermatitis; 1995 Aug; 33(2):140-1. PubMed ID: 8549145
    [No Abstract]   [Full Text] [Related]  

  • 13. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
    Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
    Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
    [No Abstract]   [Full Text] [Related]  

  • 14. First report of sweating associated with topical beta-blocker therapy.
    Schmutz JL; Barbaud A; Reichert S; Vasse JP; Trechot P
    Dermatology; 1997; 194(2):197-8. PubMed ID: 9094480
    [No Abstract]   [Full Text] [Related]  

  • 15. Psoriasis precipitated by timolol eye drops. A series of eight cases.
    Mir-Bonafé JF; Rozas-Muñoz E; Pedemonte-Sarrias E; Mir-Bonafé M; Mir-Bonafé JM; Piquero-Casals J; Puig L
    Australas J Dermatol; 2020 Feb; 61(1):e91-e93. PubMed ID: 31489616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of beta blockers in open angle glaucoma.
    Marmion VJ
    Indian J Ophthalmol; 1982 Jul; 30(4):229-31. PubMed ID: 6131867
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
    Patane' S; Marte F; Di Bella G; Pugliatti P
    Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438
    [No Abstract]   [Full Text] [Related]  

  • 19. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops.
    Mullins RJ; Lones R; Dutta B
    Australas J Dermatol; 2004 May; 45(2):151-2. PubMed ID: 15068470
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.